Table 4.
Population projections and comparison of medicine costs (US$) for implementing total risk approach versus single risk factor approach in Bangladesh
| Estimated annual total cost of CVD medication treatment per million population† | |||||||||
| Total risk approach CV risk ≥20% alone | |||||||||
| Total no of people in the general population (in thousands)* | Percentage of population aged ≥40 years requiring medication (%) | Total no of people estimated to require drug treatment (in thousands) | No of people per million population (aged 40 years and older) | Aspirin (US$) | Enalapril (US$) | Hydrochlorothiazide (US$) | Simvastatin (US$) | Total (US$) | |
| Age group | |||||||||
| Men | |||||||||
| 40–49 | 9210 | 0.4 | 3660 | 4000 | 6570.0 | 34 748.0 | 12 118.0 | 62 196.0 | 115 632.0 |
| 50–59 | 6303 | 0.1 | 596 | 1000 | 1642.5 | 8687.0 | 3029.5 | 15 549.0 | 28 908.0 |
| 60–69 | 3730 | 1.5 | 4733 | 15 000 | 24 637.5 | 130 305.0 | 45 442.5 | 233 235.0 | 433 620.0 |
| ≥70 | 1881 | 7.0 | 17 507 | 70 000 | 114 975.0 | 608 090.0 | 212 065.0 | 1 088 430.0 | 2 023 560.0 |
| Total | 21 124 | 1.0 | 20 769 | 10 000 | 16 425.0 | 86 870.0 | 30 295.0 | 155 490.0 | 289 080.0 |
| Women | |||||||||
| 40–49 | 9087 | 0.0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 50–59 | 5662 | 0.0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| 60–69 | 3257 | 0.0 | 0 | 0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ≥70 | 1638 | 1.6 | 3965 | 16 000 | 26 280.0 | 138 992.0 | 48 472.0 | 248 784.0 | 462 528.0 |
| Total | 19 644 | 0.1 | 1958 | 1000 | 1642.5 | 8687.0 | 3029.5 | 15 549.0 | 28 908.0 |
| All | |||||||||
| 40–49 | 18 296 | 0.2 | 3605 | 2000 | 3285.0 | 17 374.0 | 6059.0 | 31 098.0 | 57 816.0 |
| 50–59 | 11 965 | 0.1 | 1134 | 1000 | 1642.5 | 8687.0 | 3029.5 | 15 549.0 | 28 908.0 |
| 60–69 | 6989 | 0.7 | 4206 | 7000 | 11 497.5 | 60 809.0 | 21 206.5 | 108 843.0 | 202 356.0 |
| ≥70 | 3518 | 4.3 | 21 410 | 43 000 | 70 627.5 | 373 541.0 | 130 268.5 | 668 607.0 | 1 243 044.0 |
| Total | 40 768 | 0.5 | 20 175 | 5000 | 8212.5 | 43 435.0 | 15 147.5 | 77 745.0 | 144 540.0 |
| Single risk factor approach: BP ≥140/90 (SBP ≥140 + isolated raised DBP), % | |||||||||
| Age group | |||||||||
| Men | |||||||||
| 40–49 | 9210 | 17.1 | 156 482 | 171 000 | 280 867.5 | 1 485 477.0 | 518 044.5 | 2 658 879.0 | 4 943 268.0 |
| 50–59 | 6303 | 21.7 | 129 375 | 217 000 | 356 422.5 | 1 885 079.0 | 657 401.5 | 3 374 133.0 | 6 273 036.0 |
| 60–69 | 3730 | 30.5 | 96 228 | 305 000 | 500 962.5 | 2 649 535.0 | 923 997.5 | 4 742 445.0 | 8 816 940.0 |
| ≥70 | 1881 | 29.4 | 73 529 | 294 000 | 482 895.0 | 2 553 978.0 | 890 673.0 | 4 571 406.0 | 8 498 952.0 |
| Total | 21 124 | 22.1 | 458 995 | 221 000 | 362 992.5 | 1 919 827.0 | 669 519.5 | 3 436 329.0 | 6 388 668.0 |
| Women | |||||||||
| 40–49 | 9087 | 22.5 | 199 643 | 225 000 | 369 562.5 | 1 954 575.0 | 681 637.5 | 3 498 525.0 | 6 504 300.0 |
| 50–59 | 5662 | 30.6 | 164 475 | 306 000 | 502 605.0 | 2 658 222.0 | 927 027.0 | 4 757 994.0 | 8 845 848.0 |
| 60–69 | 3257 | 28.7 | 81 881 | 287 000 | 471 397.5 | 2 493 169.0 | 869 466.5 | 4 462 563.0 | 8 296 596.0 |
| ≥70 | 1638 | 33.7 | 83 509 | 337 000 | 553 522.5 | 2 927 519.0 | 1 020 941.5 | 5 240 013.0 | 9 741 996.0 |
| Total | 19 644 | 26.7 | 522 759 | 267 000 | 438 547.5 | 2 319 429.0 | 808 876.5 | 4 151 583.0 | 7 718 436.0 |
| All | |||||||||
| 40–49 | 18 296 | 20.2 | 364 085 | 202 000 | 331 785.0 | 1 754 774.0 | 611 959.0 | 3 140 898.0 | 5 839 416.0 |
| 50–59 | 11 965 | 26.3 | 298 189 | 263 000 | 431 977.5 | 2 284 681.0 | 796 758.5 | 4 089 387.0 | 7 602 804.0 |
| 60–69 | 6989 | 29.5 | 177 236 | 295 000 | 484 537.5 | 2 562 665.0 | 893 702.5 | 4 586 955.0 | 8 527 860.0 |
| ≥70 | 3518 | 31.6 | 157 336 | 316 000 | 519 030.0 | 2 745 092.0 | 957 322.0 | 4 913 484.0 | 9 134 928.0 |
| Total | 40 768 | 24.6 | 992 585 | 246 000 | 404 055.0 | 2 137 002.0 | 745 257.0 | 3 825 054.0 | 7 111 368.0 |
*Source: Population Projections (using 2011 Census data) Bangladesh Bureau of Statistics, Statistics and Informatics Division, Ministry of Planning
†Price for 100 tablets in US$: Aspirin (0.45), Enalapril (2.38), Hydrochlorothiazide (0.83), Simvastatine (4.29); one tablet taken per da
BP, blood pressure; CV, cardiovascular; CVD, cardiovascular disease; DBP, diastolic blood pressure; SBP, systolic blood pressure.